Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2008

View Archived Issues

HSV-2 vaccine dl5-29 effective in HSV-1 seropositive guinea pigs

Recent patents disclose new anticancer agents

G-CSF-induced neuroprotection in mouse models of ALS

Avir commences phase I study for intranasal pandemic influenza vaccine deltaFLU

Proellex reduces pain in phase II clinical trial in moderate to severe endometriosis

GlobeImmune collaborates with the NIH to develop cancer therapeutics

Targeting CaMKK2 may be useful for the treatment of obesity and diabetes

Novartis enters strategic partnership with Lonza to accelerate its biologics pipeline

Study shows bioequivalence between Insmed's INS-19 and Neupogen

Novel analgesic agents described in recent patent literature

Proteolix initiates dosing in phase Ib clinical trial of proteasome inhibitor carfilzomib

Promising preclinical results with STF-62247 in treating renal cell carcinoma

DSMB recommends discontinuation of vaccinations in phase III TRIST study of TroVax

Recent Exelixis and Nippon Zoki patents report new treatment options for metabolic disorders

Pharming reports positive results from open-label studies of Rhucin in HAE

Napo reports results from phase IIa and IIb trials of crofelemer in D-IBS

NeurogesX initiates phase I clinical trial of NGX-1998 for neuropathic pain

Nile Therapeutics initiates dosing in phase IIa clinical study of CD-NP in heart failure

Alcon terminates development of anecortave acetate in AMD

Actelion and GSK collaborate on almorexant in sleep disorders

Tredaptive approved in E.U. for dyslipidemia and primary hypercholesterolemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...